CoverorDie
July 1, 2026

Squeeze Report — July 1, 2026

Biotech dominates today's book with a cluster of binary FDA catalysts and clinical readouts, but the conviction is highest where fundamental momentum backs the technical squeeze—VERA's PDUFA and NEO's earnings beat-and-raise setup stand out. Elsewhere, heavy dilution and insider selling keep many high-short-interest names in the 'prove it' column.

15 ranked4 hot (≥80)15 squeezable (≥73)

Today's top short-squeeze candidates

  1. #1ORICOric Pharmaceuticals, Inc. Com84

    A 43% short interest is the fuel, but an active $200M ATM and no near-term catalyst make this a dilution race against covering.

    SI 43%DTC 10.3$10.83+21% 20dHealthcare
  2. #2AVTXAvalo Therapeutics, Inc. Commo81

    Shorts doubled down into a $405M offering that nearly doubled the float, creating a powder keg if Phase 3 initiation hits.

    SI 68%DTC 5.5$18.48+17% 20dHealthcare
  3. #3CRVSCorvus Pharmaceuticals, Inc. C81

    25% of float sold short · 14.4 days to cover · +24% over 20 days

    SI 25%DTC 14.4$14.94+24% 20dHealthcare
  4. #4ORKAOruka Therapeutics, Inc. Commo80

    26% of float sold short · 6.1 days to cover · +73% over 20 days

    SI 26%DTC 6.1$95.17+73% 20dHealthcare
  5. #5CADLCandel Therapeutics, Inc. Comm80

    Phase 3 NSCLC initiation and a Q4 BLA submission provide fundamental cover, but low IV caps gamma-squeeze upside.

    SI 29%DTC 7.6$10.30+21% 20dHealthcare
  6. #6GOGrocery Outlet Holding Corp. C79

    CEO and director insider buying counters a brutal quarter of impairments and store closures; Q2 must deliver a fundamental surprise.

    SI 28%DTC 10.6$9.98+22% 20dConsumer Defensive
  7. #7LIONLionsgate Studios Corp.79

    44% of float sold short · 5.7 days to cover · +10% over 20 days

    SI 44%DTC 5.7$15.31+10% 20dCommunication Services
  8. #8VERAVera Therapeutics, Inc. Class79

    A 20% short interest and 10-day cover face a July 7 PDUFA; a 26% pre-event rally suggests the squeeze may already be unwinding.

    SI 20%DTC 10.4$42.91+26% 20dHealthcare
  9. #9GPGIGPGI, Inc.78

    36% of float sold short · 18.1 days to cover · +33% over 20 days

    SI 36%DTC 18.1$15.85+33% 20dIndustrials
  10. #10RZLTRezolute, Inc. Common Stock (N78

    A 44% rally on positive interim upLIFT data fights the ghost of the sunRIZE failure; the CHI path forward is the real question.

    SI 21%DTC 5.4$5.20+44% 20dHealthcare
  11. #11CERTCertara, Inc. Common Stock77

    27% of float sold short · 7.2 days to cover · +7% over 20 days

    SI 27%DTC 7.3$6.55+7% 20dHealthcare
  12. #12REPLReplimune Group, Inc. Common S77

    A 135% rally into a third BLA attempt for RP1 leaves zero room for error ahead of the late-July AdCom.

    SI 30%DTC 4.8$11.07+23% 20dHealthcare
  13. #13PTCTPTC Therapeutics, Inc. Common76

    Sephience launch momentum and a convertible refi are positives, but 46 insider sells suggest the C-suite isn't betting on a squeeze.

    SI 16%DTC 7.8$81.57+11% 20dHealthcare
  14. #14SNDXSyndax Pharmaceuticals, Inc. C76

    Two approved drugs and a July R&D Day give fundamental cover, but cheap borrow means shorts can wait out the noise.

    SI 25%DTC 9.1$21.86+16% 20dHealthcare
  15. #15CRKComstock Resources, Inc.76

    $2.95B in debt and 46% off highs make the 30% short interest look like a fundamental bet, not a technical squeeze setup.

    SI 30%DTC 9.1$14.92+11% 20dEnergy

See the full ranked board

This is the top sliver of 15 names we rank every day. The live board carries rank history, days-to-cover fuel gauges, AI research, and a backtested signal validator.

Open the live squeeze board →